title: Skin cancer in skin of color.
abstract: In general, skin cancer is uncommon in people of color when compared to Caucasians. When it does occur, it is often associated with increased morbidity and mortality. Differences in survival rates may be attributed to skin cancers being diagnosed at a more advanced stage, and socioeconomic factors such as lack of adequate insurance coverage and lack of transportation can function as barriers to timely diagnosis and early treatment. In addition to advanced stage at presentation, malignant skin lesions in skin of color often present in an atypical fashion. Because skin cancer prevention and screening practices historically have been lower among Hispanics, Blacks, and Asians, and given the changing demographics in the United States, interventions that are tailored to each of these groups will be needed. Public educational campaigns should be expanded to educate people of all skin types with emphasis on skin cancers occurring in areas not exposed to the sun (Byrd-Miles et al., 2007), since sunlight is not as important an etiologic factor in the pathogenesis of skin cancer in people of color. Dermatologists and primary care physicians should instruct their darker-skinned patients on how to perform routine skin self-examinations. Physicians should also encourage patients to ask their specialists such as their gynecologist, dentist, and ophthalmologist to look for abnormal pigmentation during routine exams. To reduce the burden of skin cancer, several prevention methods for all people have been strongly encouraged, including monthly self-examinations, daily use of SPF 30 or greater sunscreen, sunglasses with UV-absorbing lenses, and avoiding tanning booths (American Cancer Society, 2008) (see Table 7). In addition, recommendations for clinicians to promote the prevention of skin cancer in skin of color have also been made, including closely monitoring changing pigmented lesions on the palms and soles and hyperkeratotic or poorly healing ulcers in immunosuppressed patients (Halder & Bridgeman-Shah, 1995) (see Table 7).
authors.affiliation: Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
authors.forename: Porcia T
authors.initials: PT
authors.lastname: Bradford
mesh_terms: D006801:Humans; D001213:Asian; D001741:Black or African American; D002277:Carcinoma / Q000208:ethnology / Q000401:mortality / Q000473:pathology / Q000517:prevention & control; D006630:Hispanic or Latino; D016410:Lymphoma, T-Cell, Cutaneous / Q000208:ethnology / Q000401:mortality / Q000473:pathology / Q000517:prevention & control; D008545:Melanoma / Q000208:ethnology / Q000401:mortality / Q000473:pathology / Q000517:prevention & control; D012307:Risk Factors; D012509:Sarcoma / Q000208:ethnology / Q000401:mortality / Q000473:pathology / Q000517:prevention & control; D012878:Skin Neoplasms / Q000208:ethnology / Q000401:mortality / Q000473:pathology / Q000517:prevention & control; D014481:United States / Q000453:epidemiology; D000095223:White
references.citation: Clin Exp Dermatol. 2006 Jul;31(4):542-4
references.pmid: 16716159
references.citation: J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):33-9
references.pmid: 10607317
references.citation: J Am Acad Dermatol. 1991 Jun;24(6 Pt 1):929-37
references.pmid: 1714469
references.citation: J Am Acad Dermatol. 1991 Dec;25(6 Pt 1):1005-11
references.pmid: 1810978
references.citation: N Engl J Med. 2001 Mar 29;344(13):975-83
references.pmid: 11274625
references.citation: J Am Acad Dermatol. 2007 Sep;57(3):484-501
references.pmid: 17512631
references.citation: J Am Acad Dermatol. 2008 Aug;59(2):179-206; quiz 207-8
references.pmid: 18638627
references.citation: Photochem Photobiol. 2008 May-Jun;84(3):539-49
references.pmid: 18435612
references.citation: Cancer. 1995 Jan 15;75(2 Suppl):667-73
references.pmid: 7804993
references.citation: Microbiol Mol Biol Rev. 2003 Jun;67(2):175-212, table of contents
references.pmid: 12794189
references.citation: J Clin Oncol. 2008 Jan 1;26(1):66-75
references.pmid: 18165642
references.citation: Am J Med Genet. 1997 Mar 31;69(3):299-308
references.pmid: 9096761
references.citation: J Dermatol Surg Oncol. 1981 Jul;7(7):570-1
references.pmid: 7251966
references.citation: Cancer. 1984 Oct 1;54(7):1482-8
references.pmid: 6467173
references.citation: J Am Acad Dermatol. 1996 Sep;35(3 Pt 1):355-74; quiz 375-6
references.pmid: 8784271
references.citation: Diabetes Care. 2008 Jul;31(7):e57
references.pmid: 18594056
references.citation: Curr Probl Cancer. 2008 Mar-Apr;32(2):43-87
references.pmid: 18325433
references.citation: J Am Acad Dermatol. 2006 Nov;55(5):741-60; quiz 761-4
references.pmid: 17052479
references.citation: J Drugs Dermatol. 2007 Jan;6(1):10-6
references.pmid: 17373156
references.citation: J Am Acad Dermatol. 2004 Jan;50(1):21-4; discussion 142-3
references.pmid: 14699360
references.citation: J Am Acad Dermatol. 1996 May;34(5 Pt 1):751-2
references.pmid: 8632068
references.citation: Cutis. 2001 May;67(5):403-6
references.pmid: 11381857
references.citation: Lancet Infect Dis. 2007 Apr;7(4):266-81
references.pmid: 17376384
references.citation: Aust N Z J Surg. 1971 Nov;41(2):140-7
references.pmid: 5288412
references.citation: Cancer. 2006 Mar 1;106(5):1162-8
references.pmid: 16429450
references.citation: Arch Dermatol. 2006 Jun;142(6):704-8
references.pmid: 16785372
references.citation: Arch Intern Med. 2006 Sep 25;166(17):1907-14
references.pmid: 17000949
references.citation: Cancer. 1981 Mar 15;47(6):1436-8
references.pmid: 7226069
references.citation: Arch Dermatol. 2007 Jul;143(7):854-9
references.pmid: 17638728
references.citation: Dermatol Clin. 2006 Oct;24(4):509-20, vii
references.pmid: 17010779
references.citation: Arch Dermatol. 1996 Mar;132(3):320-4
references.pmid: 8607638
references.citation: Int J Dermatol. 2007 Jul;46(7):754-6
references.pmid: 17614810
references.citation: JAMA. 1982 Oct 15;248(15):1856-9
references.pmid: 7120604
references.citation: Br J Dermatol. 2006 Apr;154(4):790-1
references.pmid: 16536838
references.citation: Cancer Causes Control. 2005 Dec;16(10):1253-9
references.pmid: 16215876
references.citation: J Cancer Educ. 1994 Summer;9(2):105-10
references.pmid: 7917894
references.citation: Dermatol Clin. 1988 Jul;6(3):397-405
references.pmid: 3048822
references.citation: Arch Dermatol. 1995 Feb;131(2):157-63
references.pmid: 7857111
references.citation: Mayo Clin Proc. 2007 Apr;82(4):490-513
references.pmid: 17418079
references.citation: Clin Exp Dermatol. 2003 Mar;28(2):138-41
references.pmid: 12653697
references.citation: Clin Exp Dermatol. 2003 Nov;28 Suppl 1:33-5
references.pmid: 14616811
references.citation: Oncogene. 2003 May 19;22(20):3042-52
references.pmid: 12789279
references.citation: J Med Virol. 2000 Jul;61(3):289-97
references.pmid: 10861635
references.citation: Cancer. 2008 Aug 1;113(3):616-27
references.pmid: 18618615
references.citation: Int J Dermatol. 1993 Sep;32(9):677-9
references.pmid: 8407099
references.citation: J Am Acad Dermatol. 1981 Nov;5(5):535-43
references.pmid: 7298919
references.citation: Arch Dermatol. 2009 Apr;145(4):427-34
references.pmid: 19380664
references.citation: N Engl J Med. 2005 Nov 24;353(21):2262-9
references.pmid: 16306523